Clinical Pharmacology Quality Assurance (CPQA) is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). CPQA is charged to develop and conduct quality assurance activities for pharmacology laboratories that collaborate in NIAID-sponsored HIV/AIDS networks. The program includes a proficiency testing component to assure the accuracy of quantitative assays; oversight of new assay development, validation and implementation; and training and certification for clinical site and laboratory staff.

Sue Siminski, Frontier Science CEO, serves as the Frontier Science Principal Investigator for CPQA. Frontier Science has participated in all phases of the program since its inception in 2007, and currently provides data management, statistical support, application development, and proficiency testing reports for CPQA.